Table 1.
General characteristics of study data.
| Trait Name | Sample Size | Number of Variants | First Author | Year | Consortium | Sex | |
|---|---|---|---|---|---|---|---|
| Exposure | |||||||
| ukb-a-25 | Alcohol intake frequency | 336,965 | 10,894,599 | Neale BM [21] | 2017 | Neale lab | M, F |
| ieu-b-4834 | Alcohol consumption | 83,626 | 7,914,362 | Howe LJ [20] | 2022 | WFGC | M, F |
| Outcome | Cancer site | ||||||
| finn-b-c3-stomach | Stomach | NA | 16,380,305 | NA | 2021 | Finngen [22] | M, F |
| finn-b-C3-liver | Liver | NA | 16,380,303 | NA | 2021 | Finngen [22] | M, F |
| ieu-b-4955 | Lung | 374,687 | 11,078,115 | Burrows [23] | 2021 | UK Biobank | M, F |
| finn-b-c3-colon | Colon | NA | 16,380,317 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-thyroid | Thyroid | NA | 16,380,316 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-cervix | Cervix | NA | 16,378,927 | NA | 2021 | Finngen [22] | M, F |
| ieu-a-1168 | Breast | 33,832 | 13,011,123 | Michailidou K [24] | 2015 | BCAC | F |
| finn-b-c3-prostate | Prostate | NA | 16,377,987 | NA | 2021 | Finngen [22] | M |
| finn-b-c3-colorectal | Colorectal | NA | 16,380,321 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-bladder | Bladder | NA | 16,380,305 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-larynx | Larynx | NA | 16,380,304 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-lip-oral | Lip/Oral/Pharynx | NA | 16,380,304 | NA | 2021 | Finngen [22] | M, F |
| ieu-b-94 | Oral cavity | 4151 | 7,510,833 | Lesseur | 2016 | OOCOC | M, F |
| finn-b-c3-brain | Brain | NA | 16,380,308 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-Biliary tract | Biliary tract | NA | 16,380,304 | NA | 2021 | Finngen [22] | M, F |
| finn-b-c3-oesphagus | Oesphagus | NA | 16,380,466 | NA | 2021 | Finngen [22] | M, F |
WFGC: Within Family GWAS Consortium. BACA: Breast Cancer Association Consortium; OOCOC: Oncoarray Oral Cavity and Oropharyngeal Cancer.